Travis Ackroyd

Travis Ackroyd is an experienced health care professional with expertise in brand marketing, market access, and health economics. They served as Senior Director of International New Product Planning for neuroscience at Eli Lilly and Company, overseeing neurodegeneration and pain portfolios. Travis held various roles at Eli Lilly, focusing on pricing and reimbursement strategies for both Canadian and global markets, particularly in Alzheimer’s disease. They earned a Master’s Degree in Management of Innovation from the University of Toronto, following dual Bachelor’s and Master’s degrees in Microbiology and Immunology from McGill University. Additionally, Travis has been involved in diversity, equity, and inclusion initiatives within their organization.